Medtech & Financing

Published on 28 Aug 2020 | 1 min read

Fund raising to enable development and launch of breast cancer detection wearable device

Overview

A technology scale-up wanted to secure investment and product development partnerships in China for their wearable breast cancer detection device.

Our Approach

With the product six months from launch, we identified product and distribution partners and developed their pitch for Chinese investment. We also structured Hong Kong and Irish based entities to specifically support market entry. Working in partnership with Southern Capital Partners, a boutique investment advisory firm, we used our networks and understanding of the Chinese market to identify and target investors.

 

​Value Created

Our client raised USD$3.8 million in pre-A round funding, with the round led by iFlytek, one of China’s leading artificial intelligence companies. As a result, product development was concluded and the product launched in Hong Kong in 2018, with further series A funding planned for China and ASEAN expansion.

 

30% Complete
Principal, Head of Global Consultancy
+44 20 7536 4103
Principal, UK Head of Rouse Consultancy
+44 20 7536 4107
Principal, Head of Global Consultancy
+44 20 7536 4103
Principal, UK Head of Rouse Consultancy
+44 20 7536 4107